An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting. [PDF]
, 2005 BACKGROUND: Polysaccharide pneumococcal vaccination for older adults is being introduced in developed country settings. Evidence of protection by this vaccine against pneumococcal pneumonia, or confirmation that illness and death from bacteraemia are ...
Cutts, Felicity T +3 more
core +1 more source
VaccinesBackground: The purpose of this study was to evaluate the knowledge, attitude, and current practices about prevention of meningococcal disease among general practitioners (GPs) and primary care pediatricians (PCPs) in Italy.
Silvia Angelillo +5 more
doaj +1 more source
Vaccine implementation: Alaska 2017 [PDF]
, 2017 Bacterial meningitis is a serious disease that causes permanent dysfunction or death; adolescents and young adults carry the greatest risk. The national Advisory Committee on Immunization Practices (ACIP) has released vaccine recommendations that include
Hulstine, Amanda
core
Current trends in research, development and production of prophylactic vaccines : Report of Vaccipharma 2015 Congress [PDF]
, 2016 On June 14-19, 2015, the IUPHAR Section of Immunopharmacology and the Cuban Society of Pharmacology, together with the Latin- American Association of Pharmacology (ALF), Finlay Vaccine Institute and other prestigious Cuban scientific institutions ...
Acevedo, R +7 more
core +1 more source
Canada Communicable Disease Report, 2020 Background: Trumenba™, a bivalent, factor-H binding protein meningococcal serogroup B (MenB-fHBP) vaccine was authorized for use in Canada in October 2017 for the prevention of invasive meningococcal disease (IMD) caused by Neisseria meningitidis ...
Robyn Harrison +3 more
doaj +1 more source
Unveiling New Aspects of Meningococcal Carriage and Disease Prevention. [PDF]
, 2015 To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Files.
Gottfredsson, Magnus
core +1 more source
Preclinical development of the quadrivalent meningococcal (ACYW) tetanus toxoid conjugate vaccine, MenQuadfi® [PDF]
, 2022 Richard D. Kensinger +1 more
openalex +1 more source
The Update, February 13, 2012 [PDF]
, 2012 The Update is a bi-weekly web newsletter published by the Iowa Department of Public Health's Bureau of Family Health. It is posted the second and fourth week of every month, and provides useful job resource information for departmental health care ...
core
Impact of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial [PDF]
, 2014 Background: Meningococcal conjugate vaccines protect individuals directly, but also confer herd protection by interrupting carriage transmission.
Baxter, David +9 more
core +1 more source
Prevention of infectious diseases in athletes. [PDF]
, 2007 The sports medicine physician may face challenging issues regarding infectious diseases when dealing with teams or highly competitive athletes who have difficulties taking time off to recover.
d'Hemecourt, Pierre, Luke, Anthony
core